FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308016781> ?p ?o ?g. }

• W4308016781 abstract "Abstract Background Relationship between cancer cell glycolysis and the landscape of tumor immune microenvironment in human cancers was investigated. Methods Forty-one fresh lung adenocarcinoma (ADC) tissues were analyzed using flow cytometry for comprehensive immunoprofiling. Formalin-fixed tissues were immunostained for hexokinase-2 (HK2) to assess cancer cell glycolysis. For validation, formalin-fixed tissues from 375 lung ADC, 118 lung squamous cell carcinoma (SqCC), 338 colon ADC, and 78 lung cancer patients treated with anti-PD-1/PD-L1 immunotherapy were immunostained for HK2, CD8, and FOXP3. Results Based on immunoprofiling of lung ADC, HK2 tumor expression was associated with the composition of lymphoid cells rather than myeloid cells. High HK2 tumor expression was associated with immunosuppressive/pro-tumorigenic features, especially decreased ratio of CD8 + T-cells to Tregs (rho = −0.415, P = 0.012). This correlation was also confirmed in four different cohorts including lung ADC and SqCC, colon ADC, and the immunotherapy cohort (rho = −0.175~-0.335, all P < 0.05). A low CD8 + T-cell to Treg ratio was associated with poor progression-free survival and overall survival in lung SqCC patients, and a shorter overall survival in the immunotherapy cohort (all, P < 0.05). Conclusion An increase in HK2 expression may contribute to shaping the immunosuppressive/pro-tumorigenic tumor microenvironment by modulating the CD8 + T-cell to Treg ratio. Targeting tumor HK2 expression might be a potential strategy for enhancing anti-tumor immunity." @default.
• W4308016781 created "2022-11-07" @default.
• W4308016781 creator A5010364211 @default.
• W4308016781 creator A5027741708 @default.
• W4308016781 creator A5030043944 @default.
• W4308016781 creator A5036978198 @default.
• W4308016781 creator A5042401127 @default.
• W4308016781 creator A5059274826 @default.
• W4308016781 creator A5061987787 @default.
• W4308016781 creator A5070098382 @default.
• W4308016781 creator A5070181255 @default.
• W4308016781 creator A5079554524 @default.
• W4308016781 date "2022-11-01" @default.
• W4308016781 modified "2023-09-30" @default.
• W4308016781 title "High tumor hexokinase-2 expression promotes a pro-tumorigenic immune microenvironment by modulating CD8+/regulatory T-cell infiltration" @default.
• W4308016781 cites W1992250154 @default.
• W4308016781 cites W2056721231 @default.
• W4308016781 cites W2072451938 @default.
• W4308016781 cites W2100039832 @default.
• W4308016781 cites W2105459360 @default.
• W4308016781 cites W2136731993 @default.
• W4308016781 cites W2146037312 @default.
• W4308016781 cites W2157739158 @default.
• W4308016781 cites W2201379305 @default.
• W4308016781 cites W2273119405 @default.
• W4308016781 cites W2291579888 @default.
• W4308016781 cites W2419439766 @default.
• W4308016781 cites W2502134830 @default.
• W4308016781 cites W2519020116 @default.
• W4308016781 cites W2527905628 @default.
• W4308016781 cites W2587048937 @default.
• W4308016781 cites W2588916311 @default.
• W4308016781 cites W2735809102 @default.
• W4308016781 cites W2752528156 @default.
• W4308016781 cites W2790724421 @default.
• W4308016781 cites W2806911036 @default.
• W4308016781 cites W2909014200 @default.
• W4308016781 cites W2913113865 @default.
• W4308016781 cites W2932702265 @default.
• W4308016781 cites W2938478188 @default.
• W4308016781 cites W2955084980 @default.
• W4308016781 cites W2981790403 @default.
• W4308016781 cites W2986542746 @default.
• W4308016781 cites W2993891115 @default.
• W4308016781 cites W3017774671 @default.
• W4308016781 cites W3040651070 @default.
• W4308016781 cites W3040958537 @default.
• W4308016781 cites W3041721952 @default.
• W4308016781 cites W3044473529 @default.
• W4308016781 cites W3049554721 @default.
• W4308016781 cites W3091822444 @default.
• W4308016781 cites W3127051356 @default.
• W4308016781 cites W3129646946 @default.
• W4308016781 cites W3134106723 @default.
• W4308016781 cites W3136367206 @default.
• W4308016781 cites W3157220577 @default.
• W4308016781 cites W900373682 @default.
• W4308016781 doi "https://doi.org/10.1186/s12885-022-10239-6" @default.
• W4308016781 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36320008" @default.
• W4308016781 hasPublicationYear "2022" @default.
• W4308016781 type Work @default.
• W4308016781 citedByCount "3" @default.
• W4308016781 countsByYear W43080167812023 @default.
• W4308016781 crossrefType "journal-article" @default.
• W4308016781 hasAuthorship W4308016781A5010364211 @default.
• W4308016781 hasAuthorship W4308016781A5027741708 @default.
• W4308016781 hasAuthorship W4308016781A5030043944 @default.
• W4308016781 hasAuthorship W4308016781A5036978198 @default.
• W4308016781 hasAuthorship W4308016781A5042401127 @default.
• W4308016781 hasAuthorship W4308016781A5059274826 @default.
• W4308016781 hasAuthorship W4308016781A5061987787 @default.
• W4308016781 hasAuthorship W4308016781A5070098382 @default.
• W4308016781 hasAuthorship W4308016781A5070181255 @default.
• W4308016781 hasAuthorship W4308016781A5079554524 @default.
• W4308016781 hasBestOaLocation W43080167811 @default.
• W4308016781 hasConcept C121608353 @default.
• W4308016781 hasConcept C126322002 @default.
• W4308016781 hasConcept C167672396 @default.
• W4308016781 hasConcept C203014093 @default.
• W4308016781 hasConcept C2776090121 @default.
• W4308016781 hasConcept C2776107976 @default.
• W4308016781 hasConcept C2776256026 @default.
• W4308016781 hasConcept C2777701055 @default.
• W4308016781 hasConcept C2778296632 @default.
• W4308016781 hasConcept C2779727006 @default.
• W4308016781 hasConcept C2781182431 @default.
• W4308016781 hasConcept C502942594 @default.
• W4308016781 hasConcept C71924100 @default.
• W4308016781 hasConcept C79484868 @default.
• W4308016781 hasConcept C8891405 @default.
• W4308016781 hasConceptScore W4308016781C121608353 @default.
• W4308016781 hasConceptScore W4308016781C126322002 @default.
• W4308016781 hasConceptScore W4308016781C167672396 @default.
• W4308016781 hasConceptScore W4308016781C203014093 @default.
• W4308016781 hasConceptScore W4308016781C2776090121 @default.
• W4308016781 hasConceptScore W4308016781C2776107976 @default.
• W4308016781 hasConceptScore W4308016781C2776256026 @default.
• W4308016781 hasConceptScore W4308016781C2777701055 @default.
• W4308016781 hasConceptScore W4308016781C2778296632 @default.
• W4308016781 hasConceptScore W4308016781C2779727006 @default.

• next